Asymmetric Total Synthesis of Antibiotic Elansolid A

J Am Chem Soc. 2022 Apr 20;144(15):6871-6881. doi: 10.1021/jacs.2c01133. Epub 2022 Apr 12.

Abstract

Elansolid A is a structurally complex polyketide macrolactone natural product that exhibits promising antibacterial properties. Its challenging asymmetric total synthesis was achieved by a convergent strategy, in which the tetrahydroindane core of the molecule and an eastern vinyl iodide moiety were combined as the main fragments. The central tetrahydroindane motif was constructed with high stereoselectivity by a bioinspired intramolecular Diels-Alder cycloaddition, generating four stereogenic centers in a single step. The stereocontrol of this key step could be achieved by virtue of a 1,3-allylic strain generated by the temporary introduction of a steric-directing iodine substituent on the substrate. The formation of the macrolactone motif that completes the synthesis was achieved via two different retrosynthetic disconnections, namely, a Suzuki-Miyaura cross-coupling or an alternative Mukaiyama esterification reaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Biological Products*
  • Cycloaddition Reaction
  • Macrolides / chemistry
  • Stereoisomerism

Substances

  • Anti-Bacterial Agents
  • Biological Products
  • Macrolides
  • elansolid A